-
Loading metrics
Open Access
Peer-reviewed
Research Article
Nevirapine- Versus Lopinavir/Ritonavir-Based Initial Therapy for HIV-1 Infection among Women in Africa: A Randomized Trial
-
Shahin Lockman ,
* E-mail: slockman@hsph.harvard.edu
Affiliations Brigham and Women's Hospital, Boston, Massachusetts, United States of America, Harvard School of Public Health, Boston, Massachusetts, United States of America, Botswana Harvard School of Public Health AIDS Initiative Partnership, Gaborone, Botswana
⨯ -
Michael Hughes,
Affiliation Harvard School of Public Health, Boston, Massachusetts, United States of America
⨯ -
Fred Sawe,
Affiliation Kenya Medical Research Institute/Walter Reed Project and US Military HIV Research Program, Kericho, Kenya
⨯ -
Yu Zheng,
Affiliation Harvard School of Public Health, Boston, Massachusetts, United States of America
⨯ -
James McIntyre,
Affiliation Anova Health Institute, Johannesburg, South Africa
⨯ -
Tsungai Chipato,
Affiliation University of Zimbabwe, Harare, Zimbabwe
⨯ -
Aida Asmelash,
Affiliation Botswana Harvard School of Public Health AIDS Initiative Partnership, Gaborone, Botswana
⨯ -
Mohammed Rassool,
Affiliation University of Witwatersrand, Johannesburg, South Africa
⨯ -
Sylvester Kimaiyo,
Affiliation Moi University Faculty of Health Sciences, Eldoret, Kenya
⨯ -
Douglas Shaffer,
Affiliation Kenya Medical Research Institute/Walter Reed Project and US Military HIV Research Program, Kericho, Kenya
⨯ -
Mina Hosseinipour,
Affiliation Kamuzu Central Hospital, University of North Carolina Project, Lilongwe, Malawi
⨯ -
Lerato Mohapi,
Affiliation Chris Hani Baragwanath Hospital, Johannesburg, South Africa
⨯ -
Francis Ssali,
Affiliation Joint Clinical Research Centre, Kampala, Uganda
⨯ -
Margret Chibowa,
Affiliation University of Alabama at Birmingham Center for Infectious Disease Research in Zambia, Lusaka
⨯ -
Farida Amod,
Affiliation University of Kwazulu-Natal, Durban, South Africa
⨯ -
Elias Halvas,
Affiliation University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America
⨯ -
Evelyn Hogg,
Affiliation Social & Scientific Systems, Silver Spring, Maryland, United States of America
⨯ -
Beverly Alston-Smith,
Affiliation National Institutes of Health, Bethesda, Maryland, United States of America
⨯ -
Laura Smith,
Affiliation Frontier Science and Technology Research Foundation, Amherst, Massachusetts, United States of America
⨯ -
Robert Schooley,
Affiliation University of California San Diego, San Diego, California, United States of America
⨯ -
John Mellors,
Affiliation University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America
⨯ -
Judith Currier,
Affiliation University of California Los Angeles, Los Angeles, California, United States of America
⨯ - [ ... ],
- the OCTANE (Optimal Combination Therapy After Nevirapine Exposure) ACTG A5208/OCTANE Study Team
- [ view all ]
- [ view less ]
Nevirapine- Versus Lopinavir/Ritonavir-Based Initial Therapy for HIV-1 Infection among Women in Africa: A Randomized Trial
- Shahin Lockman,
- Michael Hughes,
- Fred Sawe,
- Yu Zheng,
- James McIntyre,
- Tsungai Chipato,
- Aida Asmelash,
- Mohammed Rassool,
- Sylvester Kimaiyo,
- Douglas Shaffer
- Published: June 12, 2012
- https://doi.org/10.1371/journal.pmed.1001236